[Rosacea in the year 2001].
Identifieur interne : 000773 ( Ncbi/Checkpoint ); précédent : 000772; suivant : 000774[Rosacea in the year 2001].
Auteurs : M R Thissen [Pays-Bas] ; H A NeumannSource :
- Nederlands tijdschrift voor geneeskunde [ 0028-2162 ] ; 2001.
Descripteurs français
- KwdFr :
- Adulte, Anti-infectieux (administration et posologie), Coagulation par laser, Diagnostic différentiel, Femelle, Humains, Lymphoedème (étiologie), Mâle, Pays-Bas (épidémiologie), Rhinophyma (étiologie), Rosacée (), Rosacée (diagnostic), Rosacée (épidémiologie), Répartition par sexe, Télangiectasie (étiologie), Érythème (étiologie).
- MESH :
- administration et posologie : Anti-infectieux.
- diagnostic : Rosacée.
- épidémiologie : Pays-Bas, Rosacée.
- étiologie : Lymphoedème, Rhinophyma, Télangiectasie, Érythème.
- Adulte, Coagulation par laser, Diagnostic différentiel, Femelle, Humains, Mâle, Rosacée, Répartition par sexe.
- Wicri :
- geographic : Pays-Bas.
English descriptors
- KwdEn :
- Adult, Anti-Infective Agents (administration & dosage), Diagnosis, Differential, Erythema (etiology), Female, Humans, Laser Coagulation, Lymphedema (etiology), Male, Netherlands (epidemiology), Rhinophyma (etiology), Rosacea (complications), Rosacea (diagnosis), Rosacea (epidemiology), Rosacea (therapy), Sex Distribution, Telangiectasis (etiology).
- MESH :
- chemical , administration & dosage : Anti-Infective Agents.
- geographic , epidemiology : Netherlands.
- complications : Rosacea.
- diagnosis : Rosacea.
- epidemiology : Rosacea.
- etiology : Erythema, Lymphedema, Rhinophyma, Telangiectasis.
- therapy : Rosacea.
- Adult, Diagnosis, Differential, Female, Humans, Laser Coagulation, Male, Sex Distribution.
Abstract
Rosacea is a chronic skin disorder of the face. Initially erythema and telangiectasia develop, followed at a later stage by papules and papulopustules. Females between 30 and 50 years of age are most affected. Pathogenesis is not clearly understood. Finally rhinophyma and persistent lymphoedema can develop. It can be difficult to distinguish acne vulgaris, seborrheic eczema, perioral dermatitis and lupus erythematosus from rosacea. Treatment of first choice consists of topically or systemically applied antibiotics. More severe cases can be treated with isotretinoin. Erythema and telangiectasia respond well to treatment with vascular lasers.
PubMed: 11582639
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 004731
- to stream PubMed, to step Curation: 004731
- to stream PubMed, to step Checkpoint: 004731
- to stream Ncbi, to step Merge: 000773
- to stream Ncbi, to step Curation: 000773
Links to Exploration step
pubmed:11582639Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Rosacea in the year 2001].</title><author><name sortKey="Thissen, M R" sort="Thissen, M R" uniqKey="Thissen M" first="M R" last="Thissen">M R Thissen</name><affiliation wicri:level="1"><nlm:affiliation>Academisch Ziekenhuis, afd. Dermatologie, Postbus 5800, 6202 AZ Maastricht. mthis@sder.azm.nl</nlm:affiliation><country wicri:rule="url">Pays-Bas</country></affiliation></author><author><name sortKey="Neumann, H A" sort="Neumann, H A" uniqKey="Neumann H" first="H A" last="Neumann">H A Neumann</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2001">2001</date><idno type="RBID">pubmed:11582639</idno><idno type="pmid">11582639</idno><idno type="wicri:Area/PubMed/Corpus">004731</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">004731</idno><idno type="wicri:Area/PubMed/Curation">004731</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">004731</idno><idno type="wicri:Area/PubMed/Checkpoint">004731</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">004731</idno><idno type="wicri:Area/Ncbi/Merge">000773</idno><idno type="wicri:Area/Ncbi/Curation">000773</idno><idno type="wicri:Area/Ncbi/Checkpoint">000773</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Rosacea in the year 2001].</title><author><name sortKey="Thissen, M R" sort="Thissen, M R" uniqKey="Thissen M" first="M R" last="Thissen">M R Thissen</name><affiliation wicri:level="1"><nlm:affiliation>Academisch Ziekenhuis, afd. Dermatologie, Postbus 5800, 6202 AZ Maastricht. mthis@sder.azm.nl</nlm:affiliation><country wicri:rule="url">Pays-Bas</country></affiliation></author><author><name sortKey="Neumann, H A" sort="Neumann, H A" uniqKey="Neumann H" first="H A" last="Neumann">H A Neumann</name></author></analytic><series><title level="j">Nederlands tijdschrift voor geneeskunde</title><idno type="ISSN">0028-2162</idno><imprint><date when="2001" type="published">2001</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Anti-Infective Agents (administration & dosage)</term><term>Diagnosis, Differential</term><term>Erythema (etiology)</term><term>Female</term><term>Humans</term><term>Laser Coagulation</term><term>Lymphedema (etiology)</term><term>Male</term><term>Netherlands (epidemiology)</term><term>Rhinophyma (etiology)</term><term>Rosacea (complications)</term><term>Rosacea (diagnosis)</term><term>Rosacea (epidemiology)</term><term>Rosacea (therapy)</term><term>Sex Distribution</term><term>Telangiectasis (etiology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Anti-infectieux (administration et posologie)</term><term>Coagulation par laser</term><term>Diagnostic différentiel</term><term>Femelle</term><term>Humains</term><term>Lymphoedème (étiologie)</term><term>Mâle</term><term>Pays-Bas (épidémiologie)</term><term>Rhinophyma (étiologie)</term><term>Rosacée ()</term><term>Rosacée (diagnostic)</term><term>Rosacée (épidémiologie)</term><term>Répartition par sexe</term><term>Télangiectasie (étiologie)</term><term>Érythème (étiologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Anti-Infective Agents</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Netherlands</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Anti-infectieux</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Rosacea</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Rosacea</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Rosacée</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Rosacea</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Erythema</term><term>Lymphedema</term><term>Rhinophyma</term><term>Telangiectasis</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Rosacea</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Pays-Bas</term><term>Rosacée</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Lymphoedème</term><term>Rhinophyma</term><term>Télangiectasie</term><term>Érythème</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Diagnosis, Differential</term><term>Female</term><term>Humans</term><term>Laser Coagulation</term><term>Male</term><term>Sex Distribution</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Coagulation par laser</term><term>Diagnostic différentiel</term><term>Femelle</term><term>Humains</term><term>Mâle</term><term>Rosacée</term><term>Répartition par sexe</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Pays-Bas</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Rosacea is a chronic skin disorder of the face. Initially erythema and telangiectasia develop, followed at a later stage by papules and papulopustules. Females between 30 and 50 years of age are most affected. Pathogenesis is not clearly understood. Finally rhinophyma and persistent lymphoedema can develop. It can be difficult to distinguish acne vulgaris, seborrheic eczema, perioral dermatitis and lupus erythematosus from rosacea. Treatment of first choice consists of topically or systemically applied antibiotics. More severe cases can be treated with isotretinoin. Erythema and telangiectasia respond well to treatment with vascular lasers.</div></front></TEI><affiliations><list><country><li>Pays-Bas</li></country></list><tree><noCountry><name sortKey="Neumann, H A" sort="Neumann, H A" uniqKey="Neumann H" first="H A" last="Neumann">H A Neumann</name></noCountry><country name="Pays-Bas"><noRegion><name sortKey="Thissen, M R" sort="Thissen, M R" uniqKey="Thissen M" first="M R" last="Thissen">M R Thissen</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000773 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd -nk 000773 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Ncbi
|étape= Checkpoint
|type= RBID
|clé= pubmed:11582639
|texte= [Rosacea in the year 2001].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/RBID.i -Sk "pubmed:11582639" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |